This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc.announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. HRS attendees can visit Innovative Health at booth No. electrophysiology labs.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrial fibrillation (AFib). chief medical officer of Abbott's electrophysiology business.
Innovative Health, Inc. electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc. electrophysiology labs. The company recently received its 47th clearance from FDA.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during HeartRhythm Society Scientific Sessions in Boston, Massachusetts.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heartrhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
care pathways and to provide millions of Americans with the ability to just use their smartphone to obtain easy and accurate heartrhythm measurements. These measurements can enable the early detection and monitoring of heartrhythm conditions such as atrial fibrillation. and a specificity of 99.9%.1
Four heartrhythm organizations from around the globe developed the statement. It is also published in HeartRhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS.
cardiac electrophysiologist, Director of NYU Langone’s HeartRhythm Center in New York City, and lead investigator of the BIO-CONDUCT trial. Presented at HeartRhythm Society; May 19, 2024; Boston, MA. percent) and a low level of lead-related complications (1.7 percent) of Solia S leads in LBBAP at 3 months.
Our mission to combat complex heartrhythm diseases relies on optimizing interoperability. FDA 510(k) clearance and European CE Mark approval for its innovative products. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs). "As
milla1cf Fri, 01/19/2024 - 10:38 January 19, 2024 — Heartrhythm expert Sumeet Chugh, MD , associate director of the Smidt Heart Institute at Cedars-Sinai , is the recipient of this year’s American College of Cardiology ( ACC ) Distinguished Scientist Award-Clinical Domain. Photo by Cedars-Sinai.
The robotic technology represented an entirely novel way to address heartrhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
18, 2024 — The HeartRhythm Society (HRS) Board of Trustees unanimously approved the formation of HeartRhythm Advocates , a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit structure of the HRS. tim.hodson Mon, 10/21/2024 - 11:24 Oct.
The declining number of electrophysiologists pursuing academic research careers could negatively impact innovation for patients with heartrhythm disorders in the coming decades.
Wilkoff, MD, one of the most impactful and pioneering members of the HeartRhythm Society (HRS). Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs). On January 7, 2024, our cardiac electrophysiology community lost Bruce L.
At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heartrhythm every night to detect signs of Atrial Fibrillation (AFib). AFib is the most common type of irregular heartrhythm or arrhythmia. UltraSignal will help fuel more customization and innovation in health.
“It is exciting to see the convergence of our pioneering work in artificial intelligence and remote patient monitoring through this new partnership between Anumana and InfoBionic.Ai,” said Peter Noseworthy, MD, chair of the HeartRhythm Services Division of Cardiovascular Medicine at Mayo and a board director at InfoBionic.Ai. “By
The Role of Wearable Technology in Heart Health Wearable tech is designed to monitor physiological data and provide actionable insights to users. For heart health, these devices use advanced sensors to track metrics like heart rate, blood oxygen levels, and even irregular heartrhythms.
Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heartrhythm that can lead to poor blood flow. It occurs when the heart's upper chambers (atria) beat out of sync with the lower chambers (ventricles).
A research team led by Ida Anna Cappello of the HeartRhythm Management Centre of the University Hospital Brussels (VUB) has made significant strides in the field of biomedical engineering by developing innovative 3D printed surgical guides for cardiovascular procedures.
As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4
This sub-study of the National Institutes of Health-sponsored PRIMARY clinical trial is led by Smidt Heart Institute cardiologist and Chair of the Department of Cardiology Christine Albert, MD, MPH. The PRIMARY trial is directed by Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at Cedars-Sinai. and overseas for our expertise.
Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heartrhythm that can lead to poor blood flow. It occurs when the heart's upper chambers (atria) beat out of sync with the lower chambers (ventricles).
Heart rate (HR) is closely related to heartrhythm patterns, and its irregularity can imply serious health problems. Therefore, HR is used in the diagnosis of many health conditions.
Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." patients, were presented as a late-breaker at the 2024 AF Symposium.
We are thrilled to see the continuous innovation of our legacy Cryoablation portfolio alongside the approval of the PulseSelect PFA system in the U.S.," About Atrial Fibrillation and Pulsed Field Ablation AF is one of the most common and undertreated heartrhythm disorders, affecting more than 60 million people worldwide3.
The Dual Energy STSF Catheter is an exciting innovation because it allows customization of treatment by switching between radiofrequency and pulsed field energy,” said Dr. Andrea Natale, Executive Medical Director at Texas Cardiac Arrhythmia Institute at St.
It was in 1901 that people got aware when Willem Einthoven, a Dutch physiologist, developed the string galvanometer, a device capable of recording electrical signals from the heart with remarkable precision. His innovation marked a turning point in cardiac history and earned him the Nobel Prize in Physiology or Medicine in 1924.
This article will explore how AI-driven diagnostics are reshaping cardiovascular medicine and how can healthcare leaders can leverage these innovations to improve patient care and control costs.
Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? Session 104) - What Is Really New in Electrophysiology That Will Change My Practice? 24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.
History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.
It can help shorten queues to cardiologists, extend prevention and treatment to a wider group of patients, offer precise and early detection of heartrhythm abnormalities, reduce bureaucracy , and increase time for doctor-patient contact. In the long term this increases patient satisfaction with health care services.
EDT, the ACC will present Sumeet Chugh, MD , associate director of the Smidt Heart Institute, with this year’s Distinguished Scientist Award-Clinical Domain. Gupta is one of 28 structural heart cardiologists and surgeons selected for CTR’s new Project REACH.
Catheter ablation is a minimally invasive procedure performed by an electrophysiologist to treat heartrhythm disorders, including AF, by interrupting irregular electrical pathways in the heart by delivering either heat (radiofrequency ablation) or cold (cryoablation). [iv]
The abnormal heartrhythms can further lead to death because of ventricular tachycardia and ventricular fibrillation. As a result, an ECG monitor is attached to the patient immediately upon arrival at the hospital to assess their heartrhythm and provide appropriate treatment in the event of an abnormal rhythm.
Significance: Landiolol offers a new, highly selective beta-1 blocker for managing abnormally fast heartrhythms, addressing an important need in cardiac health management. Heart rate reduction within 10 minutes : Landiolol: 40%-90%. Studies on Supraventricular Tachycardia : 5 studies , a total of 317 adults.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content